Methylation-mediated regulation of E2F1 in DNA damage-induced cell death

References

• Rogoff HA, Kowalik TF. Life, death and E2F: linking proliferation control and DNA damage signaling via E2F1. Cell Cycle 2004, 3, 845–846.
   Google Scholar
• Inoshita S, Terada Y, Nakashima O, Kuwahara M, Sasaki S, Marumo F. Regulation of the G1/S transition phase in mesangial cells by E2F1. Kidney Int 1999, 56, 1238–1241.
   PubMedGoogle Scholar
• Stiewe T, Pützer BM. Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat Genet 2000, 26, 464–469.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Tan J, Zhuang L, Jiang X, Liu ET, Yu Q. Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim. Proc Natl Acad Sci USA 2005, 102, 16090–16095.
   PubMed Web of Science ®Google Scholar
• Lin WC, Lin FT, Nevins JR. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 2001, 15, 1833–1844.
   PubMed Web of Science ®Google Scholar
• Martínez-Balbás MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T. Regulation of E2F1 activity by acetylation. EMBO J 2000, 19, 662–671.
   PubMed Web of Science ®Google Scholar
• Huang J, Berger SL. The emerging field of dynamic lysine methylation of non-histone proteins. Curr Opin Genet Dev 2008, 18, 152–158.
   PubMed Web of Science ®Google Scholar
• Kouskouti A, Scheer E, Staub A, Tora L, Talianidis I. Gene-specific modulation of TAF10 function by SET9-mediated methylation. Mol Cell 2004, 14, 175–182.
   PubMedGoogle Scholar
• Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS, McKinney K, Tempst P, Prives C, Gamblin SJ, Barlev NA, Reinberg D. Regulation of p53 activity through lysine methylation. Nature 2004, 432, 353–360.
   PubMed Web of Science ®Google Scholar
• Estève PO, Chin HG, Benner J, Feehery GR, Samaranayake M, Horwitz GA, Jacobsen SE, Pradhan S. Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells. Proc Natl Acad Sci USA 2009, 106, 5076–5081.
   PubMed Web of Science ®Google Scholar
• Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA, Shi Y. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004, 119, 941–953.
   PubMed Web of Science ®Google Scholar
• Nicholson TB, Chen T. LSD1 demethylates histone and non-histone proteins. Epigenetics 2009, 4, 129–132.
   PubMed Web of Science ®Google Scholar
• Huang J, Sengupta R, Espejo AB, Lee MG, Dorsey JA, Richter M, Opravil S, Shiekhattar R, Bedford MT, Jenuwein T, Berger SL. p53 is regulated by the lysine demethylase LSD1. Nature 2007, 449, 105–108.
   PubMed Web of Science ®Google Scholar
• Wang J, Scully K, Zhu X, Cai L, Zhang J, Prefontaine GG, Krones A, Ohgi KA, Zhu P, Garcia-Bassets I, Liu F, Taylor H, Lozach J, Jayes FL, Korach KS, Glass CK, Fu XD, Rosenfeld MG. Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 2007, 446, 882–887.
   PubMed Web of Science ®Google Scholar
• Bi W, Xiao L, Jia Y, Wu J, Xie Q, Ren J, Ji G, Yuan Z. c-Jun N-terminal kinase enhances MST1-mediated pro-apoptotic signaling through phosphorylation at serine 82. J Biol Chem 2010, 285, 6259–6264.
   PubMed Web of Science ®Google Scholar
• Ohtani K, DeGregori J, Nevins JR. Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci USA 1995, 92, 12146–12150.
   PubMed Web of Science ®Google Scholar
• Couture JF, Collazo E, Hauk G, Trievel RC. Structural basis for the methylation site specificity of SET7/9. Nat Struct Mol Biol 2006, 13, 140–146.
   PubMed Web of Science ®Google Scholar
• Ivanov GS, Ivanova T, Kurash J, Ivanov A, Chuikov S, Gizatullin F, Herrera-Medina EM, Rauscher F 3rd, Reinberg D, Barlev NA. Methylation–acetylation interplay activates p53 in response to DNA damage. Mol Cell Biol 2007, 27, 6756–6769.
   PubMed Web of Science ®Google Scholar
• Morgunkova A, Barlev NA. Lysine methylation goes global. Cell Cycle 2006, 5, 1308–1312.
   PubMed Web of Science ®Google Scholar
• Wang J, Hevi S, Kurash JK, Lei H, Gay F, Bajko J, Su H, Sun W, Chang H, Xu G, Gaudet F, Li E, Chen T. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet 2009, 41, 125–129.
   PubMed Web of Science ®Google Scholar
• Shu HK, Julin CM, Furman F, Yount GL, Haas-Kogan D, Israel MA. Overexpression of E2F1 in glioma-derived cell lines induces a p53-independent apoptosis that is further enhanced by ionizing radiation. Neuro-oncology 2000, 2, 16–21.
   PubMed Web of Science ®Google Scholar
• Palacios G, Talos F, Nemajerova A, Moll UM, Petrenko O. E2F1 plays a direct role in Rb stabilization and p53-independent tumor suppression. Cell Cycle 2008, 7, 1776–1781.
   PubMed Web of Science ®Google Scholar
• Wang H, Cao R, Xia L, Erdjument-Bromage H, Borchers C, Tempst P, Zhang Y. Purification and functional characterization of a histone H3–lysine 4-specific methyltransferase. Mol Cell 2001, 8, 1207–1217.
   PubMed Web of Science ®Google Scholar
• Subramanian K, Jia D, Kapoor-Vazirani P, Powell DR, Collins RE, Sharma D, Peng J, Cheng X, Vertino PM. Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase. Mol Cell 2008, 30, 336–347.
   PubMed Web of Science ®Google Scholar
• Ea CK, Baltimore D. Regulation of NF-kappaB activity through lysine monomethylation of p65. Proc Natl Acad Sci USA 2009, 106, 18972–18977.
   PubMed Web of Science ®Google Scholar
• Yang XD, Huang B, Li M, Lamb A, Kelleher NL, Chen LF. Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit. EMBO J 2009, 28, 1055–1066.
   PubMed Web of Science ®Google Scholar
• Kontaki H, Talianidis I. Lysine methylation regulates E2F1-induced cell death. Mol Cell 2010, 39, 152–160.
   PubMed Web of Science ®Google Scholar
• Senanayake MD, Amunugama H, Boncher TD, Casero RA, Woster PM. Design of polyamine-based therapeutic agents: new targets and new directions. Essays Biochem 2009, 46, 77–94.
   PubMedGoogle Scholar
• Mimasu S, Umezawa N, Sato S, Higuchi T, Umehara T, Yokoyama S. Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1. Biochemistry 2010, 49, 6494–6503.
   PubMed Web of Science ®Google Scholar
• Huang Y, Greene E, Murray Stewart T, Goodwin AC, Baylin SB, Woster PM, Casero RA Jr. Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Proc Natl Acad Sci USA 2007, 104, 8023–8028.
   PubMed Web of Science ®Google Scholar
• Huang Y, Stewart TM, Wu Y, Baylin SB, Marton LJ, Perkins B, Jones RJ, Woster PM, Casero RA Jr. Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes. Clin Cancer Res 2009, 15, 7217–7228.
   PubMed Web of Science ®Google Scholar
• Magerl C, Ellinger J, Braunschweig T, Kremmer E, Koch LK, Höller T, Büttner R, Lüscher B, Gütgemann I. H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 and the demethylase LSD1. Hum Pathol 2010, 41, 181–189.
   PubMed Web of Science ®Google Scholar
• Lin T, Ponn A, Hu X, Law BK, Lu J. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial–mesenchymal transition. Oncogene 2010, 29, 4896–4904.
   PubMed Web of Science ®Google Scholar
• Lim S, Janzer A, Becker A, Zimmer A, Schüle R, Buettner R, Kirfel J. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 2010, 31, 512–520.
   PubMed Web of Science ®Google Scholar